Biosynex SA

EPA:ALBIO.PA

2.76 (EUR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q4
Revenue 53.750.32542.65354.345142.242157.301225.231109.78144.11416.73217.49815.24516.05414.97715.63122.0425.0977.2282.9542.6441.7151.020.4551.0480.4550.4550.3830.3830.3830.3830.2630.2630.2630.2630.2520.2520.2520.2520.1720.1720.1720.172
Cost of Revenue 64.324.66452.98549.54182.525101.64498.33574.22831.56815.95316.41810.96111.57910.9711.10616.6533.9655.7362.071.9661.4290.7790.3480.7360.3480.3480.3430.3430.3430.3430.1830.1830.1830.1830.120.120.120.120.1280.1280.1280.128
Gross Profit -10.625.661-10.3324.80359.71755.657126.89635.55312.5470.7791.084.2844.4744.0074.5255.3881.1321.4920.8840.6790.2860.2410.1080.3130.1080.1080.040.040.040.040.0790.0790.0790.0790.1320.1320.1320.1320.0450.0450.0450.045
Gross Profit Ratio -0.1970.51-0.2420.0880.420.3540.5630.3240.2840.0470.0620.2810.2790.2680.2890.2440.2220.2060.2990.2570.1670.2360.2360.2980.2360.2360.1040.1040.1040.1040.3020.3020.3020.3020.5240.5240.5240.5240.2590.2590.2590.259
Reseach & Development Expenses 01.3962.5221.8340000.5130.157000000000000000000000000000000000
General & Administrative Expenses 000000000000000000000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000000000000000000
SG&A 019.34218.28617.0217.17517.68120.92610.0635.2650.0320.033.7243.5943.6442.9453.6371.3991.6330.8780.6290.6480.5810.3550.6110.3550.3550.2310.2310.2310.2310.1880.1880.1880.1880.1530.1530.1530.1530.1070.1070.1070.107
Other Expenses -0.542.32710.7834.1214.4224.334-7.62611.611.353-0.234-0.4540000000000000000000000000000000
Operating Expenses 0.563.0657.50312.89912.75313.34728.552-1.5473.9120.2660.4843.9414.2994.8013.484.8631.6463.0670.971.7270.8351.6170.3550.8290.3550.3550.2310.2310.2310.2310.1880.1880.1880.1880.1530.1530.1530.1530.1070.1070.1070.107
Operating Income -11.1-37.404-17.835-8.09646.96442.3198.34437.18.6350.5120.5950.1780.194-0.1441.0661.301-0.5-0.51-0.101-0.157-0.532-0.511-0.468-0.479-0.468-0.468-0.191-0.191-0.191-0.191-0.1-0.1-0.1-0.1-0.023-0.023-0.023-0.023-0.062-0.062-0.062-0.062
Operating Income Ratio -0.207-0.743-0.418-0.1490.330.2690.4370.3380.1960.0310.0340.0120.012-0.010.0680.059-0.098-0.07-0.034-0.059-0.31-0.501-1.028-0.457-1.028-1.028-0.498-0.498-0.498-0.498-0.381-0.381-0.381-0.381-0.092-0.092-0.092-0.092-0.36-0.36-0.36-0.36
Total Other Income Expenses Net 11.117.658-0.578-7.951-1.115-0.942-0.092-0.972-0.393-0.116-0.0920.093-0.094-0.68-0.142-1.5710.443-0.4820.599-0.922-0.018-0.8630-0.0200-0.018-0.018-0.018-0.0180000-0.005-0.005-0.005-0.005-0.006-0.006-0.006-0.006
Income Before Tax 0-19.746-18.413-16.04745.8541.36898.25236.1288.2420.3970.5030.2710.1-0.8240.924-0.27-0.057-0.9910.498-1.079-0.55-1.374-0.468-0.498-0.468-0.468-0.209-0.209-0.209-0.209-0.1-0.1-0.1-0.1-0.029-0.029-0.029-0.029-0.068-0.068-0.068-0.068
Income Before Tax Ratio 0-0.392-0.432-0.2950.3220.2630.4360.3290.1870.0240.0290.0180.006-0.0550.059-0.012-0.011-0.1370.169-0.408-0.321-1.347-1.028-0.475-1.028-1.028-0.545-0.545-0.545-0.545-0.381-0.381-0.381-0.381-0.114-0.114-0.114-0.114-0.397-0.397-0.397-0.397
Income Tax Expense 0.11.977-0.578-2.84911.4216.58526.35210.1232.026-0.116-0.10.0710.10.150.0650.1420.0650.080.0490.0430.0570.059-0.0290.056-0.029-0.029-0.028-0.028-0.028-0.028-0.018-0.018-0.018-0.018-0.021-0.021-0.021-0.021-0.012-0.012-0.012-0.012
Net Income -21-17.553-19.394-14.97130.58533.51670.48825.1546.2160.5120.6030.3430.2-0.6740.989-0.1280.008-0.9110.547-1.036-0.493-1.316-0.44-0.443-0.44-0.44-0.181-0.181-0.181-0.181-0.082-0.082-0.082-0.082-0.007-0.007-0.007-0.007-0.056-0.056-0.056-0.056
Net Income Ratio -0.391-0.349-0.455-0.2750.2150.2130.3130.2290.1410.0310.0340.0220.012-0.0450.063-0.0060.002-0.1260.185-0.392-0.288-1.29-0.965-0.422-0.965-0.965-0.471-0.471-0.471-0.471-0.311-0.311-0.311-0.311-0.029-0.029-0.029-0.029-0.326-0.326-0.326-0.326
EPS -1.94-1.54-1.89-1.462.993.116.972.750.680.0560.0660.0380.022-0.0660.12-0.0130.001-0.130.1-0.53-0.4-1.06-0.35-0.35-0.35-0.35-0.15-0.15-0.15-0.15-0.076-0.076-0.076-0.076-0.007-0.007-0.007-0.007-0.052-0.052-0.052-0.052
EPS Diluted -1.94-1.54-1.89-1.452.973.116.842.40.650.0560.0660.0380.022-0.0660.12-0.0130.001-0.130.1-0.53-0.4-1.06-0.35-0.35-0.35-0.35-0.15-0.15-0.15-0.15-0.076-0.076-0.076-0.076-0.007-0.007-0.007-0.007-0.052-0.052-0.052-0.052
EBITDA -11.5-14.016-0.7512.15653.08144.952102.31540.17712.1980.8160.8440.4120.4270.1071.31.56-0.269-0.2280.0790.005-0.388-0.361-0.39-0.317-0.39-0.39-0.182-0.182-0.182-0.182-0.043-0.043-0.043-0.0430.0120.0120.0120.012-0.032-0.032-0.032-0.032
EBITDA Ratio -0.214-0.279-0.0180.040.3730.2860.4540.3660.2770.0490.0480.0270.0270.0070.0830.071-0.053-0.0320.0270.002-0.226-0.354-0.856-0.302-0.856-0.856-0.475-0.475-0.475-0.475-0.165-0.165-0.165-0.1650.0480.0480.0480.048-0.184-0.184-0.184-0.184